Stockreport

Lexaria Summarizes Successful Antiviral Drug Studies and Ongoing Strategy

Lexaria Bioscience Corp.  (LEXX) 
PDF All objectives evaluating DehydraTECHâ„¢ drug delivery platform successfully achievedKELOWNA, BC / ACCESSWIRE / July 22, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASD [Read more]